Terms: = Brain cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Diagnosis
27 results:
1. [Histological Classification and diagnosis of Sellar/Parasellar Tumors].
Nishioka H
No Shinkei Geka; 2023 Sep; 51(5):789-798. PubMed ID: 37743330
[TBL] [Abstract] [Full Text] [Related]
2. Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development.
Danilenko M; Zaka M; Keeling C; Crosier S; Lyman S; Finetti M; Williamson D; Hussain R; Coxhead J; Zhou P; Hill RM; Hicks D; Rand V; Joshi A; Schwalbe EC; Bailey S; Clifford SC
Acta Neuropathol; 2022 Sep; 144(3):565-578. PubMed ID: 35831448
[TBL] [Abstract] [Full Text] [Related]
3. The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (ctnnb1) genetic aberrations in patients with melanoma.
Karachaliou GS; Alkallas R; Carroll SB; Caressi C; Zakria D; Patel NM; Trembath DG; Ezzell JA; Pegna GJ; Googe PB; Galeotti JP; Ayvali F; Collichio FA; Lee CB; Ollila DW; Gulley ML; Johnson DB; Kim KB; Watson IR; Moschos SJ
BMC Cancer; 2022 Jan; 22(1):38. PubMed ID: 34986841
[TBL] [Abstract] [Full Text] [Related]
4. Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics.
Crosier S; Hicks D; Schwalbe EC; Williamson D; Leigh Nicholson S; Smith A; Lindsey JC; Michalski A; Pizer B; Bailey S; Bown N; Cuthbert G; Wharton SB; Jacques TS; Joshi A; Clifford SC
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):736-747. PubMed ID: 33826763
[TBL] [Abstract] [Full Text] [Related]
5. Immunohistochemistry or Molecular Analysis: Which Method Is Better for Subtyping Craniopharyngioma?
Fukuhara N; Iwata T; Inoshita N; Yoshimoto K; Kitagawa M; Fukuhara H; Tatsushima K; Yamaguchi-Okada M; Takeshita A; Ito J; Takeuchi Y; Yamada S; Nishioka H
Endocr Pathol; 2021 Jun; 32(2):262-268. PubMed ID: 32965631
[TBL] [Abstract] [Full Text] [Related]
6. Primary Sonic Hedgehog-activated dorsal brainstem medulloblastoma and ipsilateral cerebellar atrophy in an adult.
Demir MK; Yapıcıer Ö; Mert B; Alshareefi W; Bozbuğa M
Neuroradiol J; 2020 Feb; 33(1):75-79. PubMed ID: 31771412
[TBL] [Abstract] [Full Text] [Related]
7. Advances in the management of craniopharyngioma in children and adults.
Jensterle M; Jazbinsek S; Bosnjak R; Popovic M; Zaletel LZ; Vesnaver TV; Kotnik BF; Kotnik P
Radiol Oncol; 2019 Oct; 53(4):388-396. PubMed ID: 31652121
[TBL] [Abstract] [Full Text] [Related]
8. [Implication of BRAF V600E and ctnnb1 gene mutations in the pathological classification of craniopharyngioma].
Xu SS; Wang LM; Zhao LH; He ZL; Gong LP; Lu DH; Teng LH
Zhonghua Bing Li Xue Za Zhi; 2019 Sep; 48(9):682-687. PubMed ID: 31495087
[No Abstract] [Full Text] [Related]
9. Predisposition of Wingless Subgroup Medulloblastoma for Primary Tumor Hemorrhage.
Reisinger D; Gojo J; Kasprian G; Haberler C; Peyrl A; Azizi AA; Mayr L; Chocholous M; Kool M; Czech T; Slavc I
Neurosurgery; 2020 Apr; 86(4):478-484. PubMed ID: 31065705
[TBL] [Abstract] [Full Text] [Related]
10. Cell-free circulating tumor DNA in patients with high-grade glioma as diagnostic biomarker - A guide to future directive.
Ahmed KI; Govardhan HB; Roy M; Naveen T; Siddanna P; Sridhar P; Suma MN; Nelson N
Indian J Cancer; 2019; 56(1):65-69. PubMed ID: 30950448
[TBL] [Abstract] [Full Text] [Related]
11. Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach.
Chen X; Tong Y; Shi Z; Chen H; Yang Z; Wang Y; Chen L; Yu J
BMC Neurol; 2019 Jan; 19(1):6. PubMed ID: 30616515
[TBL] [Abstract] [Full Text] [Related]
12. DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas.
Korshunov A; Sahm F; Zheludkova O; Golanov A; Stichel D; Schrimpf D; Ryzhova M; Potapov A; Habel A; Meyer J; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M
Neuro Oncol; 2019 Feb; 21(2):214-221. PubMed ID: 30252101
[TBL] [Abstract] [Full Text] [Related]
13. Prolactin-Secreting Lung Adenocarcinoma Metastatic to the Pituitary Mimicking a Prolactinoma: A Case Report.
Yao H; Rui W; Zhang Y; Liu Y; Lin S; Tang H; Zhao W; Wu Z
Neurosurgery; 2019 Oct; 85(4):E773-E778. PubMed ID: 30137505
[TBL] [Abstract] [Full Text] [Related]
14. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM
Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700
[TBL] [Abstract] [Full Text] [Related]
15. Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features.
Yue Q; Yu Y; Shi Z; Wang Y; Zhu W; Du Z; Yao Z; Chen L; Mao Y
J Neurosurg; 2018 Jul; 129(1):27-34. PubMed ID: 28984520
[TBL] [Abstract] [Full Text] [Related]
16. Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary brain Tumors.
Ballester LY; Fuller GN; Powell SZ; Sulman EP; Patel KP; Luthra R; Routbort MJ
J Neuropathol Exp Neurol; 2017 Mar; 76(3):179-188. PubMed ID: 28395087
[TBL] [Abstract] [Full Text] [Related]
17. diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy.
Martinez-Gutierrez JC; D'Andrea MR; Cahill DP; Santagata S; Barker FG; Brastianos PK
Neurosurg Focus; 2016 Dec; 41(6):E2. PubMed ID: 27903124
[TBL] [Abstract] [Full Text] [Related]
18. Identification of a novel inherited ALK variant M1199L in the WNT type of medulloblastoma.
Trubicka J; Szperl M; Grajkowska W; Karkucińska-Więckowska A; Tarasińska M; Falana K; Dembowska-Bagińska B; Łastowska M
Folia Neuropathol; 2016; 54(1):23-30. PubMed ID: 27179218
[TBL] [Abstract] [Full Text] [Related]
19. Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles.
Hölsken A; Sill M; Merkle J; Schweizer L; Buchfelder M; Flitsch J; Fahlbusch R; Metzler M; Kool M; Pfister SM; von Deimling A; Capper D; Jones DT; Buslei R
Acta Neuropathol Commun; 2016 Feb; 4():20. PubMed ID: 26927026
[TBL] [Abstract] [Full Text] [Related]
20. Targeted BRAF and ctnnb1 next-generation sequencing allows proper classification of nonadenomatous lesions of the sellar region in samples with limiting amounts of lesional cells.
Marucci G; de Biase D; Zoli M; Faustini-Fustini M; Bacci A; Pasquini E; Visani M; Mazzatenta D; Frank G; Tallini G
Pituitary; 2015 Dec; 18(6):905-11. PubMed ID: 26156055
[TBL] [Abstract] [Full Text] [Related]
[Next]
